Physician
Florida Pediatric Group PA
Florida Pediatric Group PA was paid $7.74M by Medicaid between Jan 2018 and Dec 2024, across 68 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoFLORIDA PEDIATRIC GROUP PA
W MELBOURNE, FL 32904
W MELBOURNE, FL 32904
33aNPI1396962734assigned 04/19/2007
33bProvider typePediatrics Physician
28Total paid$7.74M
24GClaims173,628
24DCodes billed68
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Florida
Rank by total paid#32 of 971
Median peer was paid$238K
This provider vs. median32×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 821 | $43K | |
| 2019 | 25,700 | $895K | |
| 2020 | 23,050 | $903K | |
| 2021 | 26,022 | $1.26M | |
| 2022 | 39,092 | $1.92M | |
| 2023 | 37,397 | $1.76M | |
| 2024incomplete | 21,546 | $956K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 33,370 | 28,161 | $2.28M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 15,071 | 13,446 | $1.58M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.9% | 5,286 | 5,175 | $459K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 5.9% | 9,174 | 8,200 | $457K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.9% | 4,763 | 4,317 | $453K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.8% | 4,263 | 4,190 | $374K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.5% | 10,423 | 9,333 | $269K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.3% | 2,854 | 2,804 | $255K |
| S9451 | Exercise classes, non-physician provider, per session | 3.2% | 17,911 | 16,193 | $250K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.9% | 7,349 | 6,774 | $228K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.8% | 9,076 | 8,743 | $213K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 2,699 | 2,529 | $137K |
56 more codes
| 90461 | 1.7% | 4,841 | $134K | |
| 99381 | <1% | 758 | $64K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,250 | $61K |
| 90723 | <1% | 1,375 | $55K | |
| 97803 | <1% | 15,185 | $53K | |
| 90686 | <1% | 1,636 | $41K | |
| 87807 | <1% | 2,154 | $38K | |
| 83655 | <1% | 670 | $29K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 843 | $26K |
| 99177 | <1% | 1,294 | $24K | |
| 90647 | <1% | 1,369 | $23K | |
| 81003 | <1% | 1,160 | $21K | |
| 90707 | <1% | 1,395 | $18K | |
| 93000 | <1% | 531 | $17K | |
| 90633 | <1% | 1,388 | $16K | |
| 90700 | <1% | 427 | $16K | |
| 99383 | <1% | 129 | $14K | |
| 90671 | <1% | 351 | $13K | |
| 90670 | <1% | 1,978 | $13K | |
| 90680 | <1% | 1,120 | $12K | |
| 90696 | <1% | 444 | $12K | |
| 90651 | <1% | 824 | $10K | |
| 99050 | <1% | 1,652 | $9K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 805 | $9K |
| 90716 | <1% | 1,424 | $8K | |
| 90715 | <1% | 437 | $5K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 120 | $5K |
| 99188 | <1% | 311 | $5K | |
| 90734 | <1% | 454 | $4K | |
| 99382 | <1% | 46 | $4K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 24 | $4K |
| 90619 | <1% | 95 | $3K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 27 | $3K |
| 97802 | <1% | 117 | $2K | |
| 99384 | <1% | 14 | $2K | |
| 90685 | <1% | 31 | $1K | |
| 80061 | Lipid panel | <1% | 569 | $1K |
| 96127 | <1% | 725 | $1K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 13 | $1K |
| 54150 | <1% | 14 | $1K | |
| 81025 | <1% | 196 | $1K | |
| 90681 | <1% | 160 | $850.00 | |
| 90698 | <1% | 26 | $842.40 | |
| 92587 | <1% | 66 | $778.20 | |
| 90697 | <1% | 167 | $688.00 | |
| 90620 | <1% | 118 | $299.97 | |
| 90674 | <1% | 14 | $257.19 | |
| 99174 | <1% | 902 | $211.87 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 39 | $192.24 |
| A7004 | Small volume nonfiltered pneumatic nebulizer, disposable | <1% | 12 | $15.12 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 12 | $1.20 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 412 | $0.00 |
| 90744 | 0% | 16 | $0.00 | |
| 90648 | 0% | 159 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 25 | $0.00 |
| 96160 | 0% | 65 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHULTZ, DEE DEE (BILLING DEPARTMENT)